Clinical Trials Directory

Trials / Completed

CompletedNCT00631566

Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons

Prospective Study on the Incidence, Predictors, and Characteristics of Methicillin-Resistant Staphylococcus Aureus Infections and a Randomized, Double-Blind Study on Decolonization Procedures for Prevention of MRSA Infections Among HIV-Infected Persons

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
550 (actual)
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will prospectively evaluate the prevalence and incidence (over a two year period) of MRSA colonization and infection among HIV-infected military beneficiaries to determine predictors for the development of MRSA colonization and infection. This study will also investigate the utility of decolonization procedures for clearance of MRSA carriage and prevention of MRSA infections. Finally, the molecular characteristics and the antimicrobial sensitivities of isolates in this population will be determined.

Conditions

Interventions

TypeNameDescription
DRUGMupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%BACTROBAN NASAL is a white to off-white ointment that contains 2.15% w/w mupirocin calcium (equivalent to 2.0% pure mupirocin free acid) in a soft white ointment base. The inactive ingredients are paraffin and a mixture of glycerin esters (SOFTISAN 649). pHisoHex, brand of hexachlorophene detergent cleanser, is an antibacterial sudsing emulsion for topical administration. Some randomized patients will receive mupirocin (Bactroban) nasal ointment plus hexachlorophene (pHisoHex) body washes for seven days.
DRUGPlaceboSome randomized patients will receive a placebo nasal ointment (white petroleum) and a placebo body soap with no antimicrobial activity for seven days.

Timeline

Start date
2007-05-01
Primary completion
2017-05-01
Completion
2017-10-01
First posted
2008-03-07
Last updated
2023-03-03
Results posted
2018-08-16

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00631566. Inclusion in this directory is not an endorsement.